BTIG Research Issues Positive Forecast for Merit Medical Systems (NASDAQ:MMSI) Stock Price

Merit Medical Systems (NASDAQ:MMSI) had its target price upped by analysts at BTIG Research from $105.00 to $110.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the medical instruments supplier’s stock. BTIG Research‘s price target indicates a potential upside of 17.79% from the stock’s current price.

MMSI has been the topic of a number of other research reports. Barrington Research set a $114.00 target price on shares of Merit Medical Systems in a research report on Friday, July 31st. Freedom Capital assumed coverage on shares of Merit Medical Systems in a research note on Tuesday. They set a “hold” rating on the stock. Canaccord Genuity Group set a $121.00 price objective on shares of Merit Medical Systems in a research note on Friday. Raymond James Financial reissued an “outperform” rating and set a $100.00 price objective on shares of Merit Medical Systems in a report on Friday, July 31st. Finally, Robert W. Baird set a $98.00 price objective on shares of Merit Medical Systems in a research note on Friday, July 31st. Eight investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $103.36.

Merit Medical Systems Trading Up 1.3%

Shares of NASDAQ MMSI opened at $93.39 on Friday. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The business has a fifty day simple moving average of $88.68 and a two-hundred day simple moving average of $77.12. The firm has a market cap of $5.58 billion, a PE ratio of 25.12, a price-to-earnings-growth ratio of 2.30 and a beta of 0.51. Merit Medical Systems has a twelve month low of $59.74 and a twelve month high of $94.85.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.08. The business had revenue of $416.24 million for the quarter, compared to the consensus estimate of $410.56 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. The business’s revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.92 EPS. Analysts expect that Merit Medical Systems will post 3.84 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Merit Medical Systems

A number of large investors have recently added to or reduced their stakes in the company. Arizona State Retirement System boosted its holdings in shares of Merit Medical Systems by 1.1% in the 2nd quarter. Arizona State Retirement System now owns 16,459 shares of the medical instruments supplier’s stock valued at $1,141,000 after buying an additional 174 shares in the last quarter. Sowell Financial Services LLC raised its stake in shares of Merit Medical Systems by 4.0% during the 3rd quarter. Sowell Financial Services LLC now owns 4,609 shares of the medical instruments supplier’s stock worth $397,000 after acquiring an additional 179 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in Merit Medical Systems by 16.2% during the first quarter. EverSource Wealth Advisors LLC now owns 1,551 shares of the medical instruments supplier’s stock valued at $107,000 after acquiring an additional 216 shares during the last quarter. Brucke Financial Inc. lifted its position in Merit Medical Systems by 5.8% during the third quarter. Brucke Financial Inc. now owns 4,475 shares of the medical instruments supplier’s stock valued at $386,000 after acquiring an additional 247 shares during the last quarter. Finally, Signaturefd LLC boosted its stake in Merit Medical Systems by 11.4% in the third quarter. Signaturefd LLC now owns 2,465 shares of the medical instruments supplier’s stock valued at $213,000 after acquiring an additional 253 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors.

Key Stories Impacting Merit Medical Systems

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Q3 results exceeded expectations. Merit reported $416.2 million in revenue, up 8.4% year over year and above the $410.6 million consensus estimate. Non-GAAP EPS was $1.12 versus analysts’ $1.04 forecast, while GAAP EPS rose 51% to $0.70. Merit Medical Q3 2026 results
• Positive Sentiment: Growth and margins strengthened. Organic constant-currency revenue increased 9%, GAAP operating margin improved to 14.1% from 11.1%, and non-GAAP operating margin expanded to 21.3% from 19.7%. Year-to-date operating cash flow reached $175.2 million, supporting financial flexibility. Merit Medical profit report
• Positive Sentiment: Management raised full-year 2026 EPS guidance and narrowed its sales outlook, signaling confidence in earnings execution even as revenue expectations become more precise. Analysts responded by lifting price targets to $110 and $106. Analyst price-target revisions
• Positive Sentiment: Merit acquired Solo Pace, adding temporary pacing technology for transcatheter aortic valve replacement procedures and expanding its cardiac therapies platform. Solo Pace acquisition

About Merit Medical Systems

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.